Targeted extracellular nanoparticles enable intracellular detection of activated epidermal growth factor receptor in living brain cancer cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 6, 2011, Pages 896-903

  Dudu, Veronica ^a   Rotari, Veronica ^a   Vazquez, Maribel ^a  

^a City University of New York   (United States)

Author keywords

Activated EGF R; Brain cancer; Quantum dots

Indexed keywords

ACTIVATED EGF-R; BIOLOGICAL MARKERS; BIOLOGICAL PROCESS; BRAIN CANCER; CANCER CELLS; CELL FUNCTIONS; DELIVERY METHODS; DETECTION TECHNIQUE; EPIDERMAL GROWTH FACTOR RECEPTORS; EXTRACELLULAR; EXTRACELLULAR DOMAINS; MECHANISTIC STUDIES; MEDULLOBLASTOMA; QUANTUM DOT; RAPID IDENTIFICATION; RAPID METHOD; RECEPTOR ACTIVATION; SPECIFIC DETECTION;

BRAIN; CHEMICAL DETECTION; DISEASES; ENZYME ACTIVITY; PEPTIDES; SEMICONDUCTOR QUANTUM DOTS; TUMORS;

CELLS;

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; NANOPARTICLE; QUANTUM DOT;

ARTICLE; BRAIN CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RESISTANCE; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLIOMA; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PROTEIN ANALYSIS; PROTEIN BINDING;

BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; HUMANS; MEDULLOBLASTOMA; PROTEIN STRUCTURE, TERTIARY; QUANTUM DOTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 82255186332     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.05.002     Document Type: Article

References (50)

1. Alivisatos A.P., Gu W., Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng 2005, 7:55-76.
2. Pinaud F., Clarke S., Sittner A., Dahan M. Probing cellular events, one quantum dot at a time. Nat Methods 2010, 7:275-285.
3. Walkey C., Sykes E.A., Chan W.C. Application of semiconductor and metal nanostructures in biology and medicine. Hematology Am Soc Hematol Educ Program 2009, 701-707.
4. Bannai H., Levi S., Schweizer C., Dahan M., Triller A. Imaging the lateral diffusion of membrane molecules with quantum dots. Nat Protoc 2006, 1:2628-2634.
5. Dahan M., Levi S., Luccardini C., Rostaing P., Riveau B., Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003, 302:442-445.
6. Gomez-Varela D., Kohl T., Schmidt M., Rubio M.E., Kawabe H., Nehring R.B., et al. Characterization of Eag1 channel lateral mobility in rat hippocampal cultures by single-particle-tracking with quantum dots. PLoS One 2010, 5:e8858.
7. Howarth M., Liu W., Puthenveetil S., Zheng Y., Marshall L.F., Schmidt M.M., et al. Monovalent, reduced-size quantum dots for imaging receptors on living cells. Nat Methods 2008, 5:397-399.
8. Howarth M., Takao K., Hayashi Y., Ting A.Y. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci USA 2005, 102:7583-7588.
9. Kodippili G.C., Spector J., Sullivan C., Kuypers F.A., Labotka R., Gallagher P.G., et al. Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood 2009, 113:6237-6245.
10. Courty S., Luccardini C., Bellaiche Y., Cappello G., Dahan M. Tracking individual kinesin motors in living cells using single quantum-dot imaging. Nano Lett 2006, 6:1491-1495.
11. Pierobon P., Achouri S., Courty S., Dunn A.R., Spudich J.A., Dahan M., et al. Velocity, processivity, and individual steps of single myosin V molecules in live cells. Biophys J 2009, 96:4268-4275.
12. Seitz A., Surrey T. Processive movement of single kinesins on crowded microtubules visualized using quantum dots. EMBO J 2006, 25:267-277.
13. Cui B., Wu C., Chen L., Ramirez A., Bearer E.L., Li W.P., et al. One at a time, live tracking of NGF axonal transport using quantum dots. Proc Natl Acad Sci U S A 2007, 104:13666-13671.
14. Doose S., Tsay J.M., Pinaud F., Weiss S. Comparison of photophysical and colloidal properties of biocompatible semiconductor nanocrystals using fluorescence correlation spectroscopy. Anal Chem 2005, 77:2235-2242.
15. Sabharwal N., Holland E.C., Vazquez M. Live cell labeling of glial progenitor cells using targeted quantum dots. Ann Biomed Eng 2009, 37:1967-1973.
16. Akerman M.E., Chan W.C., Laakkonen P., Bhatia S.N., Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A 2002, 99:12617-12621.
17. Duan H., Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc 2007, 129:3333-3338.
18. Cho D.Y., Lin S.Z., Yang W.K., Hsu D.M., Lin H.L., Lee H.C., et al. The Role of Cancer Stem Cells (CD133(+)) in Malignant Gliomas. Cell Transplant 2011, 20:121-125.
19. Sainsbury J.R., Farndon J.R., Needham G.K., Malcolm A.J., Harris A.L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987, 1:1398-1402.
20. Hall W.A., Merrill M.J., Walbridge S., Youle R.J. Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 1990, 72:641-646.
21. Werner M.H., Humphrey P.A., Bigner D.D., Bigner S.H. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 1988, 77:196-201.
22. Lemoine N.R., Hughes C.M., Barton C.M., Poulsom R., Jeffery R.E., Klöppel G., et al. The epidermal growth factor receptor in human pancreatic cancer. J Pathol 1992, 166:7-12.
23. Veale D., Ashcroft T., Marsh C., Gibson G.J., Harris A.L. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987, 55:513-516.
24. Kang C.S., Zhang Z.Y., Jia Z.F., Wang G.X., Qiu M.Z., Zhou H.X., et al. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 2006, 13:530-538.
25. Meco D., Servidei T., Riccardi A., Ferlini C., Cusano G., Zanoni G.F., et al. Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. Neuro Oncol 2009, 11:250-259.
26. Brockmann M.A., Ulbricht U., Gruner K., Fillbrandt R., Westphal M., Lamszus K. Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 2003, 52:1391-1399. [discussion 99].
27. Katakowski M., Zheng X., Jiang F., Rogers T., Szalad A., Chopp M. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. Cancer Invest 2010, 28:1024-1030.
28. Wang X., Schneider A. HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia. Carcinogenesis 2010, 31:1202-1210.
29. Howlin J., Rosenkvist J., Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008, 10:R36.
30. Kimura F., Iwaya K., Kawaguchi T., Kaise H., Yamada K., Mukai K., et al. Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci 2010, 101:1133-1140.
31. Rodenhiser D.I., Andrews J., Kennette W., Sadikovic B., Mendlowitz A., Tuck A.B., et al. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res 2008, 10:R62.
32. Hwang Y.P., Yun H.J., Choi J.H., Han E.H., Kim H.G., Song G.Y., et al. Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling. Mol Nutr Food Res 2011.
33. Ji C., Cao C., Lu S., Kivlin R., Amaral A., Koutab N., et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 2008, 62:857-865.
34. Moss N.M., Liu Y., Johnson J.J., Debiase P., Jones J., Hudson L.G., et al. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Mol Cancer Res 2009, 7:809-820.
35. Grondin V., Seksik P., Dumont S., Thomas G., Trugnan G., Fléjou J.F., et al. Regulation of colon cancer cell proliferation and migration by MD-2 activity. Innate Immun 2010.
36. Gan Y., Shi C., Inge L., Hibner M., Balducci J., Huang Y. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 2010, 29:4947-4958.
37. Zhong M., Boseman M.L., Millena A.C., Khan S.A. Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway. Mol Cancer Res 2010, 8:1164-1172.
38. Rho J.K., Choi Y.J., Lee J.K., Ryoo B.Y., Na I.I., Yang S.H., et al. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer 2009, 63:219-226.
39. Yan X., Han J., Zhang Z., Wang J., Cheng Q., Gao K., et al. Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs. Bioelectromagnetics 2009, 30:29-35.
40. Piran U., Riordan W.J. Dissociation rate constant of the biotin-streptavidin complex. J Immunol Methods 1990, 133:141-143.
41. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005, 6:112-126.
42. Nisman R., Dellaire G., Ren Y., Li R., Bazett-Jones D.P. Application of quantum dots as probes for correlative fluorescence, conventional, and energy-filtered transmission electron microscopy. J Histochem Cytochem 2004, 52:13-18.
43. Takeuchi K., Ito F. EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS J 2010, 277:316-326.
44. Wymann M.P., Bulgarelli-Leva G., Zvelebil M.J., Pirola L., Vanhaesebroeck B., Waterfield M.D., et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996, 16:1722-1733.
45. Vu T.Q., Maddipati R., Blute T.A., Nehilla B.J., Nusblat L., Desai T.A. Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano Lett 2005, 5:603-607.
46. Lidke D.S., Nagy P., Heintzmann R., Arndt-Jovin D.J., Post J.N., Grecco H.E., et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 2004, 22:198-203.
47. Kawashima N., Nakayama K., Itoh K., Itoh T., Ishikawa M., Biju V. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots. Chemistry 2010, 16:1186-1192.
48. Arndt-Jovin D.J., Kantelhardt S.R., Caarls W., de Vries A.H., Giese A., Jovin Ast T.M. Tumor-targeted quantum dots can help surgeons find tumor boundaries. IEEE Trans Nanobioscience 2009, 8:65-71.
49. Huang D.H., Su L., Peng X.H., Zhang H., Khuri F.R., Shin D.M., et al. Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells. Nanotechnology 2009, 20:225102.
50. Lee J., Choi Y., Kim K., Hong S., Park H.Y., Lee T., et al. Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots. Bioconjug Chem 2010, 21:940-946.